Patents Assigned to CDRD VENTURES INC.
  • Somatostatin receptor antagonist compounds and methods of using the same
    Patent number: 11279732
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: March 22, 2022
    Assignee: CDRD VENTURES INC.
    Inventors: Stephen Paul Arns, James Brian Jaquith, Davy Jérémy Baudelet, Eric Roy Simonson, Richard Tom Liggins, Nag Sharwan Kumar, Tom Han Hsiao Hsieh
  • ANTI-HLA-A2 ANTIBODIES AND METHODS OF USING THE SAME
    Publication number: 20200283529
    Abstract: Provided are humanized anti-HLA-A2 antibodies. In certain aspects, the humanized anti-HLA-A2 antibodies are capable of constituting an antigen binding domain of a chimeric antigen receptor (CAR), where the CAR is capable of being expressed in a human cell such that the CAR specifically binds to HLA-A2. Also provided are CARs that include the humanized anti-HLA-A2 antibodies. Modified cells including the antibodies and CARs, as well as methods of using such modified cells are also provided.
    Type: Application
    Filed: September 19, 2018
    Publication date: September 10, 2020
    Applicants: THE UNIVERSITY OF BRITISH COLUMBIA, CDRD VENTURES INC.
    Inventors: Megan LEVINGS, Paul ORBAN, Nicholas DAWSON, Caroline LAMARCHE, Jan Peter BERGQVIST